Navigation Links
APIC Launches 'Targeting Zero' Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS
Date:12/18/2007

Campaign will Arm Infection Prevention Professionals With Guidelines and Tools

WASHINGTON, Dec. 18 /PRNewswire-USNewswire/ -- The Association for Professionals in Infection Control and Epidemiology (APIC) today announced a series of new educational initiatives aimed at eliminating healthcare-associated infections (HAIs), which include Clostridium difficile-associated disease and the three infections that the Centers for Medicare & Medicaid Services (CMS) have classified as preventable occurrences: catheter-associated urinary tract infections (UTIs), central line catheter-associated blood stream infections, and mediastinitis (a deep infection following coronary artery bypass surgery). The APIC programs will provide a comprehensive package of education, research and guidance for infection prevention and control professionals.

"As the nation's largest infection prevention organization, we are leading an effort to eradicate these infections," said Kathy L. Warye, Chief Executive Officer of APIC. "The Targeting Zero Campaign is intended to accelerate both learning and the delivery of practical tools for infection prevention professionals. In keeping with our efforts to create a culture of zero tolerance for non-compliance with measures proven to prevent HAIs, this program will clearly demonstrate to healthcare administrators and clinicians how they can implement effective strategies and simpler systems for protecting patients from these deadly infections."

Launching in January 2008, APIC's comprehensive program to address C. difficile will include a prevalence study to gain a better understanding of the scope of the problem. C. difficile is a bacterium that causes diarrhea and more serious intestinal conditions such as colitis. Over the past two years, a new strain of C. difficile has caused hospital outbreaks in several states.

APIC also intends to develop a Guide to the Elimination of C. difficile, including st
'/>"/>

SOURCE Association for Professionals in Infection Control andEpidemiology
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
2. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
3. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
4. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
7. Premier Micronutrient Launches Supplement for Hearing Health
8. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
9. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
10. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
11. PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...W YORK, Nov. 20 Clinical data from...e 35th Annual Veith Symposium shows DVT,treatment...om Bacchus,Vascular, Inc. (Santa Clara, CA) succe... in about 20 minutes. , This technique, cal...ores,blood flow more quickly and safely than curr...
(Date:11/19/2008)...N FRANCISCO, Nov. 19 Posit Science...idence at the Society for Neuroscience,Annual Con...t cognitive,training may benefit Baby Boomers. T...ess Program (TM) uses adaptive exercises that targ...are designed to drive generalized,improvements in...
(Date:11/19/2008).... Jude scientists report basic findings on critica...g how to better treat an array of disorders , ...e/ -- Scientists at St. Jude Children,s Research ...of one of the body,s enzyme workhorses called calp...evers, calpains function in many cellular processe...
(Date:11/19/2008)...riggers $5 Million Payment from Roche- , , ...Memory Pharmaceuticals Corp. (Nasdaq: MEMY ) tod...oal for its Phase 2 trial of R3487/MEM 3454, its l...ve impairment associated with schizophrenia (CIAS)...Phase 2 trial, triggering a $5.0 million payment f...
Breaking Medicine Technology:Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3MedCath Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference 7180 1CEVA Group Plc Reports Quarter 3 2007 Results 7176 1CEVA Group Plc Reports Quarter 3 2007 Results 7176 2CEVA Group Plc Reports Quarter 3 2007 Results 7176 3CEVA Group Plc Reports Quarter 3 2007 Results 7176 4Finding Ways for Seniors to Stay Safe Healthy and Home 7172 1Finding Ways for Seniors to Stay Safe Healthy and Home 7172 2Finding Ways for Seniors to Stay Safe Healthy and Home 7172 3First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD 1993 1First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD 1993 2First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD 1993 3
...007 - Xanthus,Pharmaceuticals, Inc today presented...clinical and pathological signs of chronic,disease...esentation,was made by Stephen J. Karlik, Ph.D., P... of Western Ontario, London, Ontario,together wit...the,59th American Academy of Neurology Meeting in ...
...nical (IND) In- Vitro,Studies for Promising Alzhei...) -- Samaritan,Pharmaceuticals Inc. (AMEX:LIV), a ...nce positive results were attained with its,late-s...l (SP-233),with well recognized in-vitro models. ...ect predictors,of clinical responses, laboratory a...
Other Medicine Technology:Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 2Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 3Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 2Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 3
(Date:11/22/2008)...o enough to protect themselves from stroke, heart ...News) -- It,s one of medicine,s mantras: If you ha...ill have a dramatic impact on your risk of stroke,...ople with high blood pressure still aren,t doing a...S. Centers for Disease Control and Prevention stud...
(Date:11/21/2008)... new therapies for preterm labor , , FRI...hey,ve found the switch that activates the uterine...ing that may lead to therapies for preterm labor. ... protein IP on the surface of these uterine muscle...egnancy. , But researchers from Dartmouth Medi...
(Date:11/21/2008)...v. 21 During a memoria... G. Rendell today remembered Lieutenant Governor C...ortant partner in public service, and a tireless a... "As the first woman elected lieutenant governor, ... said Governor Rendell. "Her family and her faith ...
(Date:11/21/2008)...l proved effective against Lennox-Gastaut syndrome... A new drug called Banzel (rufinamide) has been ap...orm of epilepsy called Lennox-Gastaut syndrome, th...ay. , The approval was based on results of a fo...s 4 to 30. Compared to patients who took a placebo...
Breaking Medicine News(10 mins):Health News:High Blood Pressure Stalks Many Americans 2Health News:High Blood Pressure Stalks Many Americans 3Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:FDA Approves New Drug for Severe Epilepsy 2
...AIDS in the early 1990's when she was 35, healthy,...d years earlier// of AIDS related complications, h...her less than two years to live. One day, flippi...eople, she saw an advertisement offering to buy he...
...a close friend of President Bush, a businessman-...itchman// on the president's health care proposals...th costs. He is promoting Bush's proposals to prov...... and make hospitals and doctors prices availabl...
...atisfied with their health care despite the fact t... other industrialized nations//. These were the re...d on Tuesday. In 2004 the survey revealed that Un... on medical care almost twice as much as other ind...
...iting crowd of 80,000 and the humid weather, the f... can feel cheerful about here are a spruced up// a...one-day cricket match between England and India ta...ernational Stadium Thursday. The teams were given ...
Other Medicine News:
The NU-5510 DHD AutoFlow Direct Heat Decontamination CO2 Incubator provides continuous HEPA filtration guarantying the greatest control of airborne contaminants. The dual decontamination cycles, both
...al-sized CO2 incubator with 6-sided direct heating...er-weight incubator with greater internal storage ...ss, convection air circulation optimizes culture c...al viewing window means cultures need not be distu...
...te-sized CO2 incubator with 6-sided direct heating...er-weight incubator with greater internal storage ...filtered CO2 inlet, heated outer door with glass i... optimize culture conditions and minimize contamin...
IR Autoflow Dual Chamber Over-Under Water-Jacketed CO2 Incubator
Medicine Products: